rolipram has been researched along with Cancer of Prostate in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Prostate cancer is the most commonly diagnosed non-cutaneous cancer in American men." | 1.38 | Downregulation of phosphodiesterase 4B (PDE4B) activates protein kinase A and contributes to the progression of prostate cancer. ( Inokuchi, J; Itsumi, M; Kashiwagi, E; Naito, S; Shiota, M; Uchiumi, T; Yokomizo, A, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sarwar, M | 1 |
| Sandberg, S | 1 |
| Abrahamsson, PA | 1 |
| Persson, JL | 1 |
| Kashiwagi, E | 1 |
| Shiota, M | 1 |
| Yokomizo, A | 1 |
| Itsumi, M | 1 |
| Inokuchi, J | 1 |
| Uchiumi, T | 1 |
| Naito, S | 1 |
2 other studies available for rolipram and Cancer of Prostate
| Article | Year |
|---|---|
Protein kinase A (PKA) pathway is functionally linked to androgen receptor (AR) in the progression of prostate cancer.
Topics: Cell Line, Tumor; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic Nucleotide Pho | 2014 |
Downregulation of phosphodiesterase 4B (PDE4B) activates protein kinase A and contributes to the progression of prostate cancer.
Topics: Cell Line, Tumor; Cell Proliferation; Cyclic AMP-Dependent Protein Kinases; Cyclic Nucleotide Phosph | 2012 |